VALIANTLAB

Valiant Laboratories Share Price

₹110.92 +0.92 (0.84%)

21 Nov, 2024 14:07

SIP TrendupStart SIP in VALIANTLAB

Start SIP

Performance

  • Low
  • ₹108
  • High
  • ₹112
  • 52 Week Low
  • ₹100
  • 52 Week High
  • ₹215
  • Open Price₹112
  • Previous Close₹110
  • Volume131,560

Investment Returns

  • Over 1 Month -2.94%
  • Over 3 Month + 2.52%
  • Over 6 Month -24.34%
  • Over 1 Year -39.86%
SIP Lightning

Smart Investing Starts Here Start SIP with Valiant Laboratories for Steady Growth!

Invest Now

Valiant Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -48.2
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 482
  • P/B Ratio
  • 2
  • Average True Range
  • 4.94
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.13
  • RSI
  • 43.53
  • MFI
  • 43.7

Valiant Laboratories Financials

Valiant Laboratories Technicals

EMA & SMA

Current Price
₹110.92
+ 0.92 (0.84%)
pointer
  • stock-down_img
  • Bullish Moving Average 2
  • stock-up_img
  • Bearish Moving Average 14
  • 20 Day
  • ₹112.79
  • 50 Day
  • ₹116.09
  • 100 Day
  • ₹123.23
  • 200 Day
  • ₹139.05

Resistance and Support

109.98 Pivot Speed
  • R3 114.58
  • R2 113.04
  • R1 111.52
  • S1 108.46
  • S2 106.92
  • S3 105.40

What's your outlook on Valiant Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Valiant Laboratories Ltd has an operating revenue of Rs. 111.47 Cr. on a trailing 12-month basis. An annual revenue de-growth of -43% needs improvement, Pre-tax margin of 0% needs improvement, ROE of 0% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 5 which is a POOR score indicating inconsistency in earnings, a RS Rating of 2 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 18 indicates it belongs to a strong industry group of Medical-Whlsle Drg/Suppl and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Valiant Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-12 Quarterly Results
2024-05-14 Audited Results
2024-02-09 Quarterly Results
2023-11-06 Quarterly Results

Valiant Laboratories F&O

Valiant Laboratories Shareholding Pattern

74.94%
0%
0%
17.3%
7.76%

About Valiant Laboratories

  • NSE Symbol
  • VALIANTLAB
  • BSE Symbol
  • 543998
  • Managing Director
  • Mr. Santosh S Vora
  • ISIN
  • INE0JWS01017

Similar Stocks to Valiant Laboratories

Valiant Laboratories FAQs

Valiant Laboratories share price is ₹110 As on 21 November, 2024 | 13:53

The Market Cap of Valiant Laboratories is ₹481.9 Cr As on 21 November, 2024 | 13:53

The P/E ratio of Valiant Laboratories is -48.2 As on 21 November, 2024 | 13:53

The PB ratio of Valiant Laboratories is 2 As on 21 November, 2024 | 13:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23